From: Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
 | AL (n=39) | ATTR (n=55) | P value |
---|---|---|---|
Age (years) | 64.3 ± 9.6 | 74.1 ± 8.6 | <0.01 |
Survival (months) | 18 | 48 | <0.01 |
NT pro-BNP (pMol/L) | 644 (84-7323) | 497 (43-2791) | 0.177 |
Interventricular septum (mm) | 14.2 ± 2.1 | 16.9 ± 2.2 | <0.01 |
Late gadolinium enhancement (LGE) | 36 (92.3%) | 55 (100%) | 0.07 |
RV LGE | 26 (66.7%) | 55 (100%) | <0.01 |
Circumferential subendocardial LGE | 8 (20.5%) | 2 (3.6%) | 0.01 |
Circumferential transmural LGE | 0 (0%) | 6 (10.9%) | <0.01 |
Base-apex gradient | 14 (35.9%) | 35 (63.6%) | 0.01 |
Any segment transmural LGE | 12 (30.8%) | 52 (94.5%) | <0.01 |